phytic acid has been researched along with 9,10-dimethyl-1,2-benzanthracene in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Thompson, LU; Zhang, L | 1 |
Shamsuddin, AM; Vucenik, I; Yang, GY | 2 |
Akagi, K; Futakuchi, M; Hirose, M; Hoshiya, T; Ito, N | 1 |
Bansal, M; Sakamoto, K; Shamsuddin, AM; Vucenik, I | 1 |
Bharathi, R; Gupta, KP; Singh, J | 1 |
Abd El-Aziz, MA; Abdulhameed, M; Ahmad, NS; Hussein, MR; Omran, F | 1 |
Gupta, KP; Singh, J | 1 |
Arya, M; Gupta, KP; Kaithwas, G; Parashar, P; Saraf, SA; Singh, M; Sinha, P; Tiwari, P; Tripathi, CB; Yadav, NP | 1 |
9 other study(ies) available for phytic acid and 9,10-dimethyl-1,2-benzanthracene
Article | Year |
---|---|
Phytic acid and minerals: effect on early markers of risk for mammary and colon carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Calcium, Dietary; Cell Division; Chromosome Aberrations; Chromosomes; Colon; Colonic Neoplasms; Diet; DNA; Female; Iron; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mice; Mice, Inbred C57BL; Mitotic Index; Phytic Acid | 1991 |
Inositol hexaphosphate and inositol inhibit DMBA-induced rat mammary cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Bone and Bones; Female; Inositol; Mammary Neoplasms, Experimental; Phytic Acid; Rats; Rats, Sprague-Dawley; Time Factors | 1995 |
Inhibition of mammary gland carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz[alpha]anthracene.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antioxidants; Catechols; Ear Neoplasms; Female; Hydrolyzable Tannins; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Phenylpropionates; Phytic Acid; Rats; Rats, Sprague-Dawley; Tea | 1994 |
Inhibition of rat mammary carcinogenesis by inositol hexaphosphate (phytic acid). A pilot study.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Chi-Square Distribution; Female; Mammary Neoplasms, Experimental; Phytic Acid; Pilot Projects; Rats; Rats, Sprague-Dawley | 1993 |
Comparison of pure inositol hexaphosphate and high-bran diet in the prevention of DMBA-induced rat mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Dietary Fiber; Drinking; Female; Mammary Neoplasms, Experimental; Minerals; Phytic Acid; Rats; Rats, Sprague-Dawley | 1997 |
Suppression of DMBA-induced mouse skin tumor development by inositol hexaphosphate and its mode of action.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogenicity Tests; Cell Division; DNA; Dose-Response Relationship, Drug; Epidermis; Female; Mice; Phytic Acid; Skin Neoplasms; Thymidine Kinase; Transglutaminases | 2003 |
The biochemical changes associated with phytic Acid on induced breast proliferative lesions in rats: preliminary findings.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Caspase 3; Cell Growth Processes; Female; Mammary Neoplasms, Experimental; N-Acetylneuraminic Acid; Nitric Oxide; Oxidative Stress; Phytic Acid; Rats; Rats, Sprague-Dawley | 2006 |
Inositol hexaphosphate induces apoptosis by coordinative modulation of P53, Bcl-2 and sequential activation of caspases in 7,12 dimethylbenz[a]anthracene exposed mouse epidermis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Antineoplastic Agents; Apoptosis; Carcinogens; Caspases; Disease Models, Animal; Epidermis; Female; Mice; Phytic Acid; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2008 |
Colloidal Vesicular System of Inositol Hexaphosphate to Counteract DMBA Induced Dysregulation of Markers Pertaining to Cellular Proliferation/Differentiation and Inflammation of Epidermal Layer in Mouse Model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Differentiation; Cell Proliferation; Chemistry, Pharmaceutical; Cyclin D1; Cyclooxygenase 2; Disease Models, Animal; Epidermis; Female; Inflammation; Mice; Phytic Acid; Proliferating Cell Nuclear Antigen; Tumor Cells, Cultured | 2017 |